Olutasidenib
About
Therapy type: Targeted therapy
Therapy strategy: IDH1 inhibition
Mappings
NCI Thesaurus: Olutasidenib (ncit:C129687)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.
| Organization(s) | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| FDA (1) | IDH1 p.R132C | Acute Myeloid Leukemia | Olutasidenib | |
| FDA (1) | IDH1 p.R132G | Acute Myeloid Leukemia | Olutasidenib | |
| FDA (1) | IDH1 p.R132H | Acute Myeloid Leukemia | Olutasidenib | |
| FDA (1) | IDH1 p.R132L | Acute Myeloid Leukemia | Olutasidenib | |
| FDA (1) | IDH1 p.R132S | Acute Myeloid Leukemia | Olutasidenib |